Last reviewed 01/2018

Quinagolide is a D2 dopamine receptor agonist which may be used to treat hyperprolactinaemia.

Quinagolide is as effective as bromocriptine in reducing prolactin levels and is as well tolerated as once-daily bromocriptine.

Quinagolide is more expensive than the other dopmaine receptor agonists and is probably worth considering only in patients resistant to bromocriptine and cabergoline (1).


  1. Drug and Therapeutics Bulletin 1995; 33(9):65-7.